Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants. - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

http://www.wikidata.org/entity/Q42684527

about

Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermia Dosing in neonates: special considerations in physiology and trial design.Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in Infants.Dose optimization of piperacillin/tazobactam in critically ill children.Antimicrobial treatment of serious gram-negative infections in newborns.A validated LC–MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot

P2860

Q30938796-71E5DD2C-7B77-4573-A25F-A92E6F25E0F7 Q33827819-897804BA-8C1F-4CA2-AF62-43CFE073D0DF Q34200271-6B682084-2626-4791-B7B0-F5CAD62F41F0 Q34716879-E2DC4891-9C79-49E5-A56A-27F54655C71B Q36439015-14C86626-F3AB-4397-8974-403CAA3B67A9 Q37713019-A61EDFE9-DFDA-44BB-8CC1-E2BCAD8C15E5 Q38657914-82041DEF-96ED-4441-BC78-C2D942DB4353 Q38696468-ECA7FCFF-4C6C-4806-A0D5-19F242B8F284 Q38819770-708F3697-805A-4D8E-BD37-8D49A2B6E67F Q38836711-CAB5E866-4E0A-4671-B9EF-D947C23E3F41 Q38848103-EF0B8E29-36A4-4EBA-AA59-B6E8292877E5 Q39249188-309FE1BD-FA90-4F22-8201-90B1CA678577 Q57728123-D6E69DC3-3ACE-4F00-88CB-4F84BBE02CB8

P2860

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

http://www.wikidata.org/entity/Q42684527

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

@en

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

@nl

type

label

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

@en

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

@nl

prefLabel

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

@en

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

@nl

P1433

Q42684527-7C4B4889-921B-4811-B974-8545D6875E4E

P1476

Q42684527-C9CC7068-2532-4893-B041-3692533FBD47

P2093

Q42684527-17A5B4A2-820C-44B7-9DE1-B20FCC7E03FB

Q42684527-21430ACE-A8E0-4853-BE74-54743DB9805B

Q42684527-2AE49E23-3E0D-4FBE-8138-1C5350D2FEA4

Q42684527-4FD8CB09-CA03-42E7-82FA-E1EF9766E1FF

Q42684527-8150E394-A9B3-45B6-9877-EAAFD1546F62

Q42684527-AA450C77-5A39-43C4-8C72-67A0AF79BEFA

Q42684527-B3FCAC07-4488-455B-A980-41988EE01990

Q42684527-D459DEDD-5039-4A0E-9AF9-F84627100F3A

Q42684527-DB1490D4-B13B-401D-9E6C-9C242FEB3B78

Q42684527-EE9C73CF-C0E3-4885-AD5B-8977E9AD4B55

P2860

Q42684527-01D2DF7A-515D-464A-9061-4DAF0CF26C55

Q42684527-0810473F-88A7-4E90-A7B9-59668B063D92

Q42684527-1BA0B088-040A-4F15-B27D-165844A40F08

Q42684527-21D3A228-EF5C-4D52-987A-BEDF6330525A

Q42684527-284CE3D1-54B3-45C7-9224-3AC85F82FE99

Q42684527-4EF3A23C-C87F-4E7E-9BC6-2B888C3C37F3

Q42684527-4FA80295-44A8-4863-B5AE-BEE9563EFEF1

Q42684527-52BFB228-4FA6-412D-9952-755C4B0C9E2D

Q42684527-5333BF32-F885-44E4-8988-29963EABD2F4

Q42684527-84E1AC04-6058-44C7-A2F3-190FCEA20C14

P2888

Q42684527-6F13E1DD-AE75-4716-BF2E-00F3D52060DB

P304

Q42684527-33B846A7-04C6-40EA-B6D8-5906DB6E1EFD

P31

Q42684527-3128A10E-34CE-4C3C-9B3B-3C32DEDFEDC6

P356

Q42684527-CA5F340B-F386-4D61-B39A-59D5B75F2505

P433

Q42684527-18D90561-959E-4B8E-8F1E-FFD8BD79AE2B

P478

Q42684527-1C3E358B-07D2-467A-86B0-B767B87B2569

P577

Q42684527-B5FEE7C1-A0BB-4DDC-B3BA-36FBF16F86ED

P698

Q42684527-51709372-3ACE-4FD7-B98A-FBECEA37C033

P356

S00228-012-1413-4

P1433

European Journal of Clinical Pharmacology

P1476

Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.

@en

P2093

Chao Chen

http://www.w3.org/2001/XMLSchema#string

Dan Wu

http://www.w3.org/2001/XMLSchema#string

Di Cao

http://www.w3.org/2001/XMLSchema#string

Qin Li

http://www.w3.org/2001/XMLSchema#string

Wenjing Shi

http://www.w3.org/2001/XMLSchema#string

Yewei Chen

http://www.w3.org/2001/XMLSchema#string

Yi Wang

http://www.w3.org/2001/XMLSchema#string

Yiqing Zhu

http://www.w3.org/2001/XMLSchema#string

Yun Cao

http://www.w3.org/2001/XMLSchema#string

Zhiping Li

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic scaling: consensus or controversy?

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Drug toxicity in the neonate

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation

A simple estimate of glomerular filtration rate in full-term infants during the first year of life.

Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults.

P2888

s00228-012-1413-4

P304

1223-1233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-012-1413-4

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23354809

http://www.w3.org/2001/XMLSchema#string